Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons

被引:39
|
作者
Rao, Haripriya Vittal
Thirumangalakudi, Lakshmi
Desmond, Paula
Grammas, Paula
机构
[1] Texas Tech Univ, Hlth Sci, Garrison Inst Aging, Lubbock, TX 79430 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA
关键词
Alzheimer's disease; Bim; cyclin-dependent kinase 4; cyclin D1; neuronal cell death; thrombin;
D O I
10.1111/j.1471-4159.2006.04389.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thrombin, a multifunctional serine protease, is neurotoxic in vitro and in vivo. Thrombin has been shown to be increased in Alzheimer's disease (AD) and other neuropathological conditions and could be a mediator of pathological neuronal cell death in the brain. The mechanisms of thrombin-induced neuronal cell death are incompletely understood. The objective of this study is to explore mechanisms that contribute to thrombin-induced neuronal apoptosis focusing on the role of cell cycle regulators and the pro-apoptotic protein Bim (Bcl-2-interacting mediator of cell death) in this process. Our data show that thrombin treatment of primary cerebral cortical cultures results in dose-dependent apoptotic cell death. Exposure of neuronal cultures to thrombin leads to induction of cell cycle proteins cyclin D1 and cyclin E, at both mRNA and protein levels. In addition, thrombin treatment causes the appearance of cyclin-dependent kinase 4 (cdk4) and expression of the pro-apoptotic protein Bim. Inhibition of cdk4 prevents both induction of Bim expression and thrombin-induced neuronal apoptosis. These data demonstrate that thrombin-induced apoptosis proceeds via cell cycle activation involving cdk4 resulting in induction of Bim. Thus, cell cycle proteins could be therapeutic targets in diseases such as AD where thrombin has been implicated.
引用
收藏
页码:498 / 505
页数:8
相关论文
共 50 条
  • [1] Cdk4/Cyclin D1 kinase, a universal and critical regulator of apoptosis
    Katayama, K
    Dobashi, Y
    Kitagawa, M
    Kawai, M
    Kadoya, Y
    Kameya, T
    ANTICANCER RESEARCH, 2003, 23 (1A) : 235 - 243
  • [2] EXPRESSION OF CYCLIN D1 AND CDK4 IN OSTEOSARCOMA OF THE JAWS
    司晓辉
    刘正
    ChineseJournalofCancerResearch, 2001, (02) : 65 - 68
  • [3] Identification of CDK4 sequences involved in cyclin D1 and p16 binding
    Coleman, KG
    Wautlet, BS
    Morrissey, D
    Mulheron, J
    Sedman, SA
    Brinkley, P
    Price, S
    Webster, KR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18869 - 18874
  • [4] Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas
    Kim, H
    Ham, EK
    Kim, YI
    Chi, JG
    Lee, HS
    Park, SH
    Jung, YM
    Myung, NK
    Lee, MJ
    Jang, JJ
    CANCER LETTERS, 1998, 131 (02) : 177 - 183
  • [5] Immunoreactivity of cyclin D1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat
    Li, Y
    Chopp, M
    Powers, C
    Jiang, N
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (08): : 846 - 856
  • [6] Neuroprotective Effects of 17β-Estradiol against Thrombin-Induced Apoptosis in Primary Cultured Cortical Neurons
    Bao, Lei
    Zhou, Su
    Zhao, Hui
    Zu, Jie
    He, Qianqian
    Ye, Xinchun
    Cui, Guiyun
    PHARMACOLOGY, 2015, 96 (5-6) : 284 - 289
  • [7] SUPPRESSION OF CYCLIN D1 BUT NOT CDK4 OR CYCLIN-A WITH INDUCTION OF MELANOMA TERMINAL DIFFERENTIATION
    RIEBER, MS
    RIEBER, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (01) : 422 - 427
  • [8] Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma
    Molenaar, Jan J.
    Ebus, Marli E.
    Koster, Jan
    van Sluis, Peter
    van Noesel, Carel J. M.
    Versteeg, Rogier
    Caron, Huib N.
    CANCER RESEARCH, 2008, 68 (08) : 2599 - 2609
  • [9] cyclin D1、CDK4在肺癌中的表达
    王华新
    唐建武
    周春辉
    孙雷
    李连宏
    郑仁恕
    临床与实验病理学杂志, 2003, (03) : 326 - 327
  • [10] Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix
    Cheung, TH
    Yu, MMY
    Lo, KWK
    Yim, SF
    Chung, TKH
    Wong, YF
    CANCER LETTERS, 2001, 166 (02) : 199 - 206